- Home
- PHAR vs ODC Comparison
PHAR vs ODC Comparison
Compare PHAR & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- ODC
- Stock Information
- Founded
- PHAR 1988
- ODC 1941
- Country
- PHAR Netherlands
- ODC United States
- Employees
- PHAR N/A
- ODC N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- ODC Miscellaneous manufacturing industries
- Sector
- PHAR Health Care
- ODC Consumer Discretionary
- Exchange
- PHAR Nasdaq
- ODC Nasdaq
- Market Cap
- PHAR 618.3M
- ODC 305.8M
- IPO Year
- PHAR N/A
- ODC N/A
- Fundamental
- Price
- PHAR $8.20
- ODC $42.41
- Analyst Decision
- PHAR Strong Buy
- ODC
- Analyst Count
- PHAR 3
- ODC 0
- Target Price
- PHAR $27.00
- ODC N/A
- AVG Volume (30 Days)
- PHAR 5.6K
- ODC 30.2K
- Earning Date
- PHAR 03-13-2025
- ODC 03-06-2025
- Dividend Yield
- PHAR N/A
- ODC 2.16%
- EPS Growth
- PHAR N/A
- ODC 36.22
- EPS
- PHAR N/A
- ODC 3.09
- Revenue
- PHAR $285,745,000.00
- ODC $454,094,000.00
- Revenue This Year
- PHAR $20.08
- ODC N/A
- Revenue Next Year
- PHAR $9.22
- ODC N/A
- P/E Ratio
- PHAR N/A
- ODC $13.57
- Revenue Growth
- PHAR 30.64
- ODC 6.61
- 52 Week Low
- PHAR $6.65
- ODC $29.48
- 52 Week High
- PHAR $13.20
- ODC $46.50
- Technical
- Relative Strength Index (RSI)
- PHAR 36.29
- ODC 49.08
- Support Level
- PHAR $8.49
- ODC $42.30
- Resistance Level
- PHAR $9.35
- ODC $43.51
- Average True Range (ATR)
- PHAR 0.55
- ODC 1.00
- MACD
- PHAR -0.17
- ODC -0.23
- Stochastic Oscillator
- PHAR 12.14
- ODC 33.09
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About ODC Oil-Dri Corporation Of America
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.